Company Executives

$OABIW Management Team

Name / Title	Age	Compensation	Sex	Social Media

Board of Directors

From the proxy statement filed Apr 29, 2026

Directors

serving now

Independent

1 of 2

stated in the proxy; 5 not stated

Average tenure

3.0 years

from year joined

CEO also chairs the board

John Higgins

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
Jennifer Cochran, Ph.D.	54	2022 4 years	Not stated	Nominating and Corporate Governance · Chair Science and Technology	None stated	$148,188
Matthew W. Foehr CEO	53	2022 4 years	Not independent	None stated	Viking Therapeutics, Inc.	Paid as CEO
Steve Crouse	53	2025 1 year	Not stated	Audit Science and Technology	None stated	$254,950
Philip J. Gotwals, Ph.D.	63	2025 1 year	Not stated	Human Capital Management and Compensation Science and Technology	Capricor Therapeutics, Inc.	$253,816
Steve Love	57	2023 3 years	Not stated	Audit · Chair Human Capital Management and Compensation · Chair	None stated	$151,588
Carolyn R. Bertozzi, Ph.D.	59	2022 4 years	Not stated	Science and Technology · Chair	Eli Lilly	$148,188
John Higgins Board chair	56	2022 4 years	Independent	Audit Nominating and Corporate Governance	Bio-Techne Corporation	$150,688

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 29, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Comments

Company Executives

$OABIW Management Team

Board of Directors

Related-party transactions

No related-party transactions disclosed